Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Oktober 2017 02:50 ET | Quelle: AroCell AB

AroCell AB: announces that a distribution agreement has been signed with Pathway Diagnostics Ltd, for distribution of the AroCell TK 210 ELISA test in United Kingdom and Ireland.

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} "We very much look forward to...
26. September 2017 05:00 ET | Quelle: AroCell AB

AroCell AB: AroCell Research Poster on TK1 / TK 210 ELISA in Prostate Cancer has been accepted for presentation at the UK National Cancer Research Institute (NCRI) Annual Meeting November 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} AroCell AB (publ) announces today that a...
22. September 2017 05:30 ET | Quelle: AroCell AB

AroCell AB: TK 210 ELISA abstract on in-vitro studies of cancer drugs has been accepted for presentation at the National Cancer Research Institute (NCRI) UK symposium

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} AroCell AB (publ) announces today that an...
18. September 2017 08:15 ET | Quelle: AroCell AB

AroCell AB: New application for AroCell TK 210 ELISA opens new opportunities for drug development research

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Uppsala September 18,...
24. August 2017 02:15 ET | Quelle: AroCell AB

AroCell AB: Interim report, Q2 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} AroCell AB (publ) Reporting period...
18. Mai 2017 12:30 ET | Quelle: AroCell AB

Beslut vid årsstämman i AroCell AB (publ) 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESSMEDDELANDE 18 MAJ 2017 Beslut...
11. Mai 2017 02:25 ET | Quelle: AroCell AB

AroCell (publ): Interim report for period 1 January - 31 March 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} AroCell AB (publ) Interim...
13. April 2017 05:00 ET | Quelle: AroCell AB

AroCell AB: KALLELSE TILL ÅRSSTÄMMA I AROCELL AB (PUBL)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ...
16. Februar 2017 02:15 ET | Quelle: AroCell AB

AroCell AB: (publ) Year-End Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Report for period 1 January - 31 December...
24. Januar 2017 05:45 ET | Quelle: AroCell AB

AroCell AB: Research poster on prostate cancer has been accepted by the American Association for Cancer Research (AARC)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} AroCell AB (publ) announces today that a research...

Vorherige Seite

Nächste Seite